Patents by Inventor Gregory Allan Hudalla II

Gregory Allan Hudalla II has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11407797
    Abstract: Described herein are modified gal1 monomers that can contain one or more mutated cysteines and/or can be pegylated. Also described herein are modified gal1 dimers, trimers, and tetramers that can contain one or more modified gal1 monomers as described herein. Also described herein are pharmaceutical formulations containing a modified gal1 monomer, dimer, trimer, and/or tetramer. Also described herein are methods of making the modified gal1 polypeptides and complexes thereof. Also described herein are methods of using the modified gal1 polypeptides and complexes thereof.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: August 9, 2022
    Assignee: University of Florida Research Foundation, Incorporated
    Inventors: Gregory Allan Hudalla, II, Margaret Mary Fettis
  • Publication number: 20200262882
    Abstract: Described herein are modified gall monomers that can contain one or more mutated cysteines and/or can be pegylated. Also described herein are modified gall dimers, trimers, and tetramers that can contain one or more modified gall monomers as described herein. Also described herein are pharmaceutical formulations containing a modified gall monomer, dimer, trimer, and/or tetramer. Also described herein are methods of making the modified gall polypeptides and complexes thereof. Also described herein are methods of using the modified gall polypeptides and complexes thereof.
    Type: Application
    Filed: October 10, 2018
    Publication date: August 20, 2020
    Applicant: University of Florida Research Foundation, Incorporated
    Inventors: Gregory Allan Hudalla II, Margaret Mary Fettis